IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Indian Pharma Firm to Spin off Generics and Ingredients

11:22 AM MST | November 20, 2007 | Deepti Ramesh

Glenmark Pharmaceuticals (Mumbai) says it plans to hive off its generic drugs and active pharmaceutical ingredient (API) businesses to create a new, wholly owned subsidiary, Glenmark Generics Ltd. (GGL). Glenmark expects to list the new company on the Indian stock exchanges via an initial public offering (IPO) by the first quarter of the fiscal year ending March 31, 2009. Glenmark Pharmaceuticals specializes in manufacturing branded pharmaceuticals and the discovery of new molecules, as well as making generics and APIs. Glenmark expects the generics and API...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily newsvv and analysis from the entire global chemical enterprise on chemweek.com
  • Free mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa